Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Oncology

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.29.3.541PMID 16865269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy Compounds in Cervical Cancer Cells Primed by Reconstitution of p53 Function after Short Interfering RNA-Mediated Degradation of Human Papillomavirus 18 E6 mRNA: Opposite Effect of siRNA in Combination with Different Drugss⃞

  2005cited by this paper
• Morpholino antisense oligomer targeting human midkine: Its application for cancer therapy

  2005cited by this paper
• The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer.

  2005cited by this paper
• Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.

  2004cited by this paper
• A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics

  2004cited by this paper
• Gel-Based Application of siRNA to Human Epithelial Cancer Cells Induces RNAi-Dependent Apoptosis

  2004cited by this paper
• Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients.

  2004cited by this paper
• Potential of Atelocollagen-Mediated Systemic Antisense Therapeutics for Inflammatory Disease

  2004cited by this paper
• Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma Cells

  2003cited by this paper
• RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells

  2003cited by this paper
• siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

  2003cited by this paper
• Correlation of p16INK4A Overexpression with Human Papillomavirus Infection in Cervical Adenocarcinomas

  2003cited by this paper
• American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.

  2003cited by this paper
• Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women

  2003cited by this paper
• In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA.

  2003cited by this paper
• P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.

  2003cited by this paper
• 5′-,3′-Inverted Thymidine-modified Antisense Oligodeoxynucleotide Targeting Midkine

  2002cited by this paper
• Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

  2002cited by this paper
• Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

  2002cited by this paper
• Advances in the Development of Ribozymes and Antisense Oligodeoxynucleotides as Antiviral Agents for Human Papillomaviruses

  2002cited by this paper
• siRNA-directed inhibition of HIV-1 infection

  2002cited by this paper
• Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.

  2001cited by this paper
• Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines.

  2001cited by this paper
• Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines

  1999cited by this paper
• New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet

  1999cited by this paper
• A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

  1995cited by this paper
• Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.

  1995cited by this paper
• Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product

  1991cited by this paper
• Viruses in human cancers.

  1991cited by this paper
• Conservation of E6 and E7 regions of human papillomavirus types 16 and 18 present in cervical cancers.

  1987cited by this paper
• Presence of human papillomavirus type‐16 and type‐18 DNA sequences and their expression in cervical cancers and cell lines from japanese patients

  1986cited by this paper

• siRNA-based therapeutics in hormone-driven cancers: Advancements and benefits over conventional treatments.

  2025cites this paper
• Exploitation of Biocomputational Approaches for siRNA‐Mediated Gene Silencing of HPV: A Novel Therapeutic Strategy for Cervical Cancer

  2025cites this paper
• Small Interfering RNA Drug Delivery System in Cancer

  2024cites this paper
• The Reservoir of Persistent Human Papillomavirus Infection; Strategies for Elimination Using Anti-Viral Therapies

  2022cites this paper
• Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy.

  2021cites this paper
• AGO-accessible anticancer siRNAs designed with synergistic miRNA-like activity

  2021cites this paper
• RNA-based gene targeting therapies for human papillomavirus driven cancers.

  2021cites this paper
• Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer.

  2020cites this paper
• TWEAK/Fn14 Interaction Confers Aggressive Properties to Cutaneous Squamous Cell Carcinoma.

  2019cites this paper
• Nb-induced stabilisation of p53 in HPV-infected cells

  2019cites this paper
• Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy.

  2019cites this paper
• Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology

  2019cites this paper
• Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7

  2018cites this paper
• Therapeutic startegies for human papillomavirus infection and associated cancers.

  2018cites this paper
• 8 Development of Vaccines and Gene Therapy Against HPV Infection and Cervical Cancer

  2017influential citation
• Evaluation of RNA and DNA extraction from liquid‐based cytology specimens

  2016cites this paper
• Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.

  2016cites this paper
• Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel

  2016cites this paper
• Nanotechnology in Gene Knockdown and miRNA Replacement In Vivo

  2016cites this paper
• Frequency of E 6 and E 7 Oncogenes of Human Papillomavirus Types 16 and 18 in Cervical Cancer Patients in Pakistani Women

  2016cites this paper
• Glyoxalase I is differentially expressed in cutaneous neoplasms and contributes to the progression of squamous cell carcinoma.

  2015influential citation
• Using RNA aptamers to manipulate the functions of Human papillomaviruses (HPV)

  2015cites this paper
• Utility of MicroRNAs and siRNAs in Cervical Carcinogenesis

  2015cites this paper
• Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy.

  2015cites this paper
• Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer

  2015cites this paper
• E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines

  2015cites this paper
• Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis

  2014cites this paper
• Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease

  2014cites this paper
• Harnessing RNAi nanomedicine for precision therapy

  2014cites this paper
• HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models

  2014cites this paper
• Local siRNA delivery by non-viral vectors

  2014cites this paper
• MicroRNAs in Heart Failure: Is the Picture Becoming Less miRky?

  2014cites this paper
• Polycation-based nanoparticles for RNAi-mediated cancer treatment.

  2014influential citation
• HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia

  2013cites this paper
• Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest

  2013cites this paper
• Anti-cancer effect of adenovirus p 53 on human cervical cancer cell growth in vitro and in vivo

  2013cites this paper
• Exploration de nouvelles voies thérapeutiques contre le cancer du col de l'utérus : approche combinée par adénovirus et ARN interférence

  2013cites this paper
• Nanomedicines for Systemic Delivery of RNAi Therapeutics

  2013cites this paper
• Dendrimer-based RNA interference delivery for cancer therapy

  2013cites this paper
• Advancements in the field of intravaginal siRNA delivery.

  2013cites this paper
• Nanobiomaterial-Based Short Interfering RNA Delivery Systems

  2012cites this paper
• RNA interference as a plausible anticancer therapeutic tool.

  2012cites this paper
• Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation

  2012cites this paper
• Development of Vaccines and Gene Therapy Against HPV Infection and Cervical Cancer

  2012influential citation
• Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.

  2012cites this paper
• 5 Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection

  2012cites this paper
• Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer.

  2012cites this paper
• University of Groningen Modulation of the TRAIL apoptotic pathway to optimize chemoradiation in preclinical models of cervical cancer

  2012cites this paper
• Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection

  2012cites this paper
• PROFILAXIS Y TRATAMIENTO EN LA INFECCIÓN POR VPH Y EL CÁNCER CERVICAL

  2012influential citation
• Effective gene silencing and inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs

  2012cites this paper
• Targeted treatments for cervical cancer: a review

  2012cites this paper
• Targeting the Human Papillomavirus E6 and E7 Oncogenes through Expression of the Bovine Papillomavirus Type 1 E2 Protein Stimulates Cellular Motility

  2011cites this paper
• Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models

  2011cites this paper
• Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development

  2011cites this paper
• Silencing of hpv16 e6 and e7 oncogenic activities by small interference rna induces autophagy and apoptosis in human cervical cancer cells

  2011cites this paper
• Special delivery: targeted therapy with small RNAs

  2011cites this paper
• Different contribution of bovine papillomavirus type 1 oncoproteins to the transformation of equine fibroblasts.

  2011cites this paper
• Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs

  2011cites this paper
• RNA de interferencia: biogénesis, mecanismos moleculares y sus aplicaciones en cáncer cervical

  2010cites this paper
• Future prospect of RNA interference for cancer therapies.

  2010cites this paper
• RNAi nanomedicines: challenges and opportunities within the immune system

  2010cites this paper
• RNA de interferencia: biogénesis, mecanismos moleculares y sus aplicaciones en cáncer cervical

  2010cites this paper
• Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: a mini-review.

  2010cites this paper
• Enhanced gene delivery and/or efficacy by functional peptide and protein.

  2009cites this paper
• Local and systemic delivery of siRNAs for oligonucleotide therapy.

  2009cites this paper
• Small interfering RNA targeting bovine papillomavirus type 1 E2 induces apoptosis in equine sarcoid transformed fibroblasts.

  2009cites this paper
• Systemic delivery of siRNA specific to tumor mediated by atelocollagen: Combined therapy using siRNA targeting Bcl‐xL and cisplatin against prostate cancer

  2009cites this paper
• Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAs

  2009cites this paper
• RNA interference silences the human papillomavirus 6b/11 early gene E7 in vitro and in vivo

  2009cites this paper
• siRNA delivery systems for cancer treatment.

  2009cites this paper
• Modular protein engineering in emerging cancer therapies.

  2009cites this paper
• Advances in Systemic siRNA Delivery.

  2009cites this paper
• Cellular delivery in vivo of siRNA-based therapeutics.

  2008cites this paper
• HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.

  2008cites this paper
• Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.

  2008cites this paper
• Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo

  2007cites this paper
• Validation of the Pitts unified theory of prostate cancer, late‐onset hypogonadism and carcinoma: the role of steroid 5α‐reductase and steroid aromatase

  2007cites this paper
• Nouvelle stratégie thérapeutique contre les cancers associés au virus d'Epstein-Barr : étude in vitro de l'inhibition du cycle lytique du virus par ARN interférence

  2007cites this paper
• Viral origins of human cancer.

  2007cites this paper
• Antisense RNA directed to the human papillomavirus type 16 E7 mRNA from herpes simplex virus type 1 derived vectors is expressed in CaSki cells and downregulates E7 mRNA

  2007influential citation
• Atelocollagen-mediated drug discovery technology

  2007cites this paper
• [Application of atelocollagen-mediated siRNA delivery for RNAi therapies].

  2007cites this paper